Risk factors for nuclear opalescence in a longitudinal study

American Journal of Epidemiology

Volumn 147, Issue 1, 1998, Pages 36-41

  Leske, M Cristina ^a   Chylack Jr , Leo T ^b   He, Qimei ^a   Wu, Suh Yuh ^a   Schoenfeld, Elinor ^a   Friend, Judith ^b   Wolfe, John ^a,b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cataract; Education; Ethnic groups; Gout; Longitudinal studies; Proportional hazards models; Risk factors; Smoking

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SENILE CATARACT; SMOKING;

EID: 0031983528     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009364     Document Type: Article

References (36)

1. Thylefors B. The role of international ophthalmology in blindness prevention. (Editorial). Am J Ophthalmol 1995;119: 229-30.
2. Thylefors B, Nêgrel AD, Pararajasegaram R, et al. Global data on blindness. Bull World Health Organ 1995;73:115-21.
3. Steinberg EP, Javitt JC, Sharkey PD. The content and cost of cataract surgery, Arch Ophthalmol 1993;111:1041-9.
4. Cataract Management Guideline Panel. Cataract in adults: management of functional impairment. Clinical practice guidelines, number 4. Rockville, MD: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993. (AHCPR publication no. 93-0542).
5. Leske MC, Chylack LT, Wu S, et al. The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
6. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataract. Arch Ophthalmol 1989; 107:670-6.
7. The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataract. Am J Epidemiol 1991;133:541-53.
8. Mares-Perlman JA, Brady WE, Klein R, et al. Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. Invest Ophthalmol Vis Sci 1995;36:276-88.
9. Ritter LL, Klein BE, Klein R, et al. Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch Ophthalmol 1993;111:113-17.
10. Leske MC, Wu SY, Hyman L, et al. Biochemical factors in the Lens Opacities Case-Control Study. Arch Ophthalmol 1995; 113:1113-19.
11. Leske MC, Chylack LT, Wu SY, et al. Incidence and progression of nuclear opacities in the Longitudinal Study of Cataract. Ophthalmology 1996;103:705-12.
12. Chylack LT, Leske MC, Sperduto R, et al. Lens opacities classification system. Arch Ophthalmol 1988;106:330-4.
13. Leske MC, Chylack LT, Sperduto R, et al. Evaluation of a lens opacities classification system. Arch Ophthalmol 1988;106: 327-9.
14. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. Arch Ophthalmol 1993;111: 831-6.
15. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distribution. J Am Stat Assoc 1989;84:1065-73.
16. Lin DY. MULCOX: a computer program for the Cox regression analysis of multiple failure time variables. Comput Methods Programs Biomed 1990;32:125-35.
17. Lin DY. MULCOX2: a general computer program for the Cox regression analysis of multivariate failure time data. Comput Methods Programs Biomed 1993;40:279-93.
18. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 1986;124:916-25.
19. Leske MC, Connell AMS, Wu SY, et al. Prevalence of lens opacities, The Barbados Eye Study. Arch Ophthalmol 1997; 115:105-11.
20. Hanna C, Dreis MW, Cosgrove KW. Cataract associated with allopurinol therapy. Am J Ophthalmol 1982;94:137-40.
21. Lerman S, Megaw JM, Gardner MS. Allopurinol therapy and cataractogenesis in humans. Am J Ophthalmol 1982;94: 141-6.
22. Lerman S, Megaw JM, Fraunfelder FT. Further studies on allopurinol therapy and human cataractogenesis. Am J Ophthalmol 1984;97:205-9.
23. Jick H, Brandt DE. Allopurinol and cataract. Am J Ophthalmol 1984;98:355-8.
24. Clair WK, Chylack LT Jr, Cook EF, et al. Allopurinol use and the risk of cataract formation. Br J Ophthalmol 1989;73: 173-6.
25. Klein BE, Klein R, Linton KL, et al. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prev Med 1993;9:27-30.
26. West S, Munoz B, Schein OD, et al. Cigarette smoking and risk of progression of nuclear opacities. Arch Ophthalmol 1995;113:1377-80.
27. West S, Munoz B, Emmett EA, et al. Cigarette smoking and risk of nuclear opacities. Arch Ophthalmol 1989;107:1166-9.
28. Christen WG, Manson JA, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA 1992;268:989-93.
29. Hankinson SE, Willett WC, Golditz GA, et al. A prospective study of cigarette smoking and risk of cataract in women. JAMA 1992;268:994-8.
30. Flaye DE, Sullivan KN, Cullinan TR, et al. Cataract and cigarette smoking: the City Eye Study. Eye 1989;3:379-84.
31. Ramakrishnan S, Sulochana KN, Selvaraj T. Smoking of beedies and cataract: cadmium and vitamin C in the lens and blood. Br J Ophthalmol 1995;79:202-6.
32. Shalini VK, Luthra M, Srinivas L. Oxidative damage to the eye lens caused by cigarette smoke and fuel smoke condensates. Indian J Biochem Biophys 1994;31:261-6.
33. Harding JJ. Cigarettes and cataract: cadmium or a lack of vitamin C? (Editorial). Br J Ophthalmol 1995;79:199-200.
34. Heiba IM, Elston RC, Klein BE, et al. Genetic etiology of nuclear cataract: evidence of a major gene. Am J Med Genet 1993;47:1208-14.
35. The Italian-American Cataract Study Group. Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. Am J Ophthalmol 1994;118:623-31.
36. Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. New York: Oxford University Press, 1986:101.